To investigate SF3A2's biological role in CRC, we reduced endogenous SF3A2 in HCT116 and LOVO cells through lentiviral vector introduction expressing two distinct shRNAs (shSF3A2 #1 and #2). This evidence concerns the gene SF3A2 and colorectal carcinoma.